医学
重症肌无力
弱点
肌肉无力
抗体
神经肌肉接头
乙酰胆碱受体
内科学
免疫学
外科
受体
神经科学
生物
出处
期刊:JAMA
[American Medical Association]
日期:2022-02-01
卷期号:327 (5): 417-417
标识
DOI:10.1001/jama.2022.0177
摘要
A new medication that reduces abnormal antibodies involved in causing skeletal muscle weakness has received FDA approval for adults with generalized myasthenia gravis who test positive for the antiacetylcholine receptor (AChR) antibody.
科研通智能强力驱动
Strongly Powered by AbleSci AI